Header Logo

Connection

HOP S. TRAN CAO to Humans

Back to Details
This is a "connection" page, showing publications HOP S. TRAN CAO has written about Humans.
HOP S. TRAN CAO
Connection Strength
1.225
Humans
  1. Advancing Robotic Liver Resection: The Sling Technique for Improved Hepatic Retraction. Ann Surg Oncol. 2025 Jul; 32(7):5021.
    View in: PubMed
    Score: 0.025
  2. CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2025 Feb; 32(2):1021-1032.
    View in: PubMed
    Score: 0.024
  3. Robotic Hepatic Parenchymal Transection Techniques: A Choice Between Imperfect Tools. Ann Surg Oncol. 2025 Jan; 32(1):438-439.
    View in: PubMed
    Score: 0.024
  4. A propensity score matched cost analysis of robotic versus open hepatectomy. HPB (Oxford). 2024 Nov; 26(11):1379-1386.
    View in: PubMed
    Score: 0.024
  5. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist. 2024 Jun 03; 29(6):e803-e810.
    View in: PubMed
    Score: 0.024
  6. Exceptional pathologic response to preoperative therapy in the context of mutational profiling for colorectal liver metastases. J Gastrointest Surg. 2024 Jul; 28(7):1181-1184.
    View in: PubMed
    Score: 0.023
  7. Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809. Ann Surg Oncol. 2024 Aug; 31(8):4837-4838.
    View in: PubMed
    Score: 0.023
  8. A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol. 2024 Mar; 31(3):1833.
    View in: PubMed
    Score: 0.023
  9. Great Debates: Neoadjuvant Therapy Should be Routinely Given for High-Risk Cholangiocarcinoma. Ann Surg Oncol. 2023 12; 30(13):7960-7965.
    View in: PubMed
    Score: 0.022
  10. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. 2023 Nov; 30(12):7309-7318.
    View in: PubMed
    Score: 0.022
  11. Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer. Ann Surg Oncol. 2023 Jun; 30(6):3560-3568.
    View in: PubMed
    Score: 0.022
  12. Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). 2023 07; 25(7):758-765.
    View in: PubMed
    Score: 0.022
  13. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes? HPB (Oxford). 2023 04; 25(4):472-480.
    View in: PubMed
    Score: 0.021
  14. Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis. Ann Surg Oncol. 2022 Dec; 29(13):8455.
    View in: PubMed
    Score: 0.021
  15. Protocolized Training of Advanced Practice Providers for Robotic Surgery Improves the Quality of Intraoperative Assistance. JSLS. 2022 Jul-Sep; 26(3).
    View in: PubMed
    Score: 0.021
  16. Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol. 2022 Sep; 126(4):658-666.
    View in: PubMed
    Score: 0.020
  17. Robot-assisted liver resection: the real benefit so far. Langenbecks Arch Surg. 2022 Aug; 407(5):1779-1787.
    View in: PubMed
    Score: 0.020
  18. Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol. 2022 Aug; 29(8):5156-5164.
    View in: PubMed
    Score: 0.020
  19. ASO Author Reflections: Robotic Hepatobiliary Surgery with Fluorescence Guidance-Taking Advantage of the Available Technology. Ann Surg Oncol. 2021 10; 28(11):6835-6836.
    View in: PubMed
    Score: 0.019
  20. Robotic Completion Radical Cholecystectomy with Fluorescence Guidance. Ann Surg Oncol. 2021 Oct; 28(11):6834.
    View in: PubMed
    Score: 0.019
  21. Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience. Ann Surg Oncol. 2021 Oct; 28(11):6725-6735.
    View in: PubMed
    Score: 0.019
  22. Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer. Mol Imaging. 2021; 2021:5540569.
    View in: PubMed
    Score: 0.019
  23. ASO Author Reflections: Role of Neoadjuvant Therapy in Surgically Resectable Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2021 10; 28(11):6736-6737.
    View in: PubMed
    Score: 0.019
  24. Hospital clinical staging accuracy for upper gastrointestinal malignancy. J Surg Oncol. 2020 Dec; 122(8):1630-1638.
    View in: PubMed
    Score: 0.018
  25. Malnutrition in elective surgery: How traditional markers might be failing surgeons and patients. Surgery. 2020 12; 168(6):1144-1151.
    View in: PubMed
    Score: 0.018
  26. ASO Author Reflections: The Role of the Robot in Liver Surgery: An Evolution in Progress. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):897-898.
    View in: PubMed
    Score: 0.018
  27. Portal Vein Embolization for Perihilar Cholangiocarcinoma: A Story Worth Repeating. Ann Surg Oncol. 2020 Jul; 27(7):2120-2121.
    View in: PubMed
    Score: 0.018
  28. Benign hepatic incidentalomas. Curr Probl Surg. 2019 09; 56(9):100642.
    View in: PubMed
    Score: 0.017
  29. Nodal downstaging as a treatment goal for node-positive pancreatic cancer. Surgery. 2019 06; 165(6):1144-1150.
    View in: PubMed
    Score: 0.016
  30. Adjuvant Therapy for Biliary Tract Cancers: Desperately Seeking Data. J Oncol Pract. 2018 12; 14(12):719-720.
    View in: PubMed
    Score: 0.016
  31. National Failure of Surgical Staging for T1b Gallbladder Cancer. Ann Surg Oncol. 2019 Feb; 26(2):604-610.
    View in: PubMed
    Score: 0.016
  32. ASO Author Reflections: Role of Preoperative Chemotherapy in the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol. 2018 12; 25(Suppl 3):792-793.
    View in: PubMed
    Score: 0.016
  33. Robotic port-site hernias after general surgical procedures. J Surg Res. 2018 10; 230:7-12.
    View in: PubMed
    Score: 0.015
  34. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer. 2018 Jan 01; 124(1):74-83.
    View in: PubMed
    Score: 0.015
  35. Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 2017 09; 162(3):557-567.
    View in: PubMed
    Score: 0.015
  36. Rate of Organ Space Infection Is Reduced with the Use of an Air Leak Test During Major Hepatectomies. J Gastrointest Surg. 2017 01; 21(1):85-93.
    View in: PubMed
    Score: 0.014
  37. Improved perioperative outcomes with minimally invasive distal pancreatectomy: results from a population-based analysis. JAMA Surg. 2014 Mar; 149(3):237-43.
    View in: PubMed
    Score: 0.012
  38. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. J Gastrointest Surg. 2014 Feb; 18(2):269-78; discussion 278.
    View in: PubMed
    Score: 0.011
  39. Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer. Hepatogastroenterology. 2012 Sep; 59(118):1994-9.
    View in: PubMed
    Score: 0.010
  40. A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry. Surgery. 2012 Aug; 152(2):145-51.
    View in: PubMed
    Score: 0.010
  41. Imaging of the interaction of cancer cells and the lymphatic system. Adv Drug Deliv Rev. 2011 Sep 10; 63(10-11):886-9.
    View in: PubMed
    Score: 0.010
  42. Submillimeter-resolution fluorescence laparoscopy of pancreatic cancer in a carcinomatosis mouse model visualizes metastases not seen with standard laparoscopy. J Laparoendosc Adv Surg Tech A. 2011 Jul-Aug; 21(6):485-9.
    View in: PubMed
    Score: 0.010
  43. Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer. Anticancer Res. 2010 Nov; 30(11):4415-22.
    View in: PubMed
    Score: 0.009
  44. A preliminary report on the clinical experience with AlloDerm in breast reconstruction and its radiologic appearance. Am Surg. 2010 Oct; 76(10):1123-6.
    View in: PubMed
    Score: 0.009
  45. Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Mol Cancer Ther. 2010 Jul; 9(7):2068-78.
    View in: PubMed
    Score: 0.009
  46. Fluorescence laparoscopy imaging of pancreatic tumor progression in an orthotopic mouse model. Surg Endosc. 2011 Jan; 25(1):48-54.
    View in: PubMed
    Score: 0.009
  47. Cystic neoplasms of the pancreas. Surg Oncol Clin N Am. 2010 Apr; 19(2):267-95.
    View in: PubMed
    Score: 0.009
  48. Development of the transgenic cyan fluorescent protein (CFP)-expressing nude mouse for "Technicolor" cancer imaging. J Cell Biochem. 2009 May 15; 107(2):328-34.
    View in: PubMed
    Score: 0.008
  49. Performance measures of surgeon-performed colonoscopy in a Veterans Affairs medical center. Surg Endosc. 2009 Oct; 23(10):2364-8.
    View in: PubMed
    Score: 0.008
  50. The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review. BJS Open. 2025 Jul 01; 9(4).
    View in: PubMed
    Score: 0.006
  51. Parenchymal-sparing hepatectomy vs single-stage major hepatectomy for bilateral colorectal liver metastases: a higher rate of microscopically positive margins is not associated with increased local recurrence after parenchymal-sparing hepatectomy. J Gastrointest Surg. 2025 Jul; 29(7):102070.
    View in: PubMed
    Score: 0.006
  52. Impact of Nonhepatectomy Opioid Reduction Efforts on Posthepatectomy Opioid Prescription: Analysis of 2,005 Patients. J Am Coll Surg. 2025 Apr 01; 240(4):474-487.
    View in: PubMed
    Score: 0.006
  53. Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-center Study. Ann Surg Oncol. 2025 Jun; 32(6):4374-4382.
    View in: PubMed
    Score: 0.006
  54. Robotic Central Pancreatectomy: Patient Selection and Surgical Approach. Ann Surg Oncol. 2025 Jun; 32(6):4128-4129.
    View in: PubMed
    Score: 0.006
  55. Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience. Ann Surg Oncol. 2025 Jun; 32(6):4352-4362.
    View in: PubMed
    Score: 0.006
  56. Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer. Clin Cancer Res. 2025 Jan 17; 31(2):387-402.
    View in: PubMed
    Score: 0.006
  57. Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2025 Apr; 32(4):2425-2434.
    View in: PubMed
    Score: 0.006
  58. Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration. Ann Surg Oncol. 2025 Mar; 32(3):1752-1761.
    View in: PubMed
    Score: 0.006
  59. Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma. Oncology. 2025; 103(6):490-497.
    View in: PubMed
    Score: 0.006
  60. Advancing minimally invasive hepato-pancreato-biliary surgery: barriers to adoption and equitable access. Surg Endosc. 2024 10; 38(10):5643-5650.
    View in: PubMed
    Score: 0.006
  61. Advancing minimally invasive hepato-pancreato-biliary surgery: ensuring safety with implementation. Surg Endosc. 2024 08; 38(8):4365-4373.
    View in: PubMed
    Score: 0.006
  62. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Med. 2024 Jun; 13(12):e7434.
    View in: PubMed
    Score: 0.006
  63. Current Perspectives and Progress in Preoperative Portal Vein Embolization with Stem Cell Augmentation (PVESA). Stem Cell Rev Rep. 2024 07; 20(5):1236-1251.
    View in: PubMed
    Score: 0.006
  64. Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy. Ann Surg Oncol. 2024 Jul; 31(7):4361-4370.
    View in: PubMed
    Score: 0.006
  65. Reproducibility and efficiency of liver volumetry using manual method and liver analysis software. HPB (Oxford). 2024 07; 26(7):911-918.
    View in: PubMed
    Score: 0.006
  66. Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress? Ann Surg Oncol. 2024 May; 31(5):3062-3068.
    View in: PubMed
    Score: 0.006
  67. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2547-2556.
    View in: PubMed
    Score: 0.006
  68. Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis. Langenbecks Arch Surg. 2023 Dec 26; 409(1):16.
    View in: PubMed
    Score: 0.006
  69. What Defines the Value of Minimally Invasive Surgery for Cancer Patients? Ann Surg Oncol. 2024 Apr; 31(4):2204-2207.
    View in: PubMed
    Score: 0.006
  70. Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg. 2024 Jul; 233:17-23.
    View in: PubMed
    Score: 0.006
  71. Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma. Oncology. 2023; 101(11):730-737.
    View in: PubMed
    Score: 0.006
  72. Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2023 11; 27(11):2388-2395.
    View in: PubMed
    Score: 0.006
  73. ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 09; 30(9):5401-5402.
    View in: PubMed
    Score: 0.005
  74. Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5390-5400.
    View in: PubMed
    Score: 0.005
  75. Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study. Ann Surg Oncol. 2023 Aug; 30(8):4904-4911.
    View in: PubMed
    Score: 0.005
  76. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist. 2023 04 06; 28(4):327-332.
    View in: PubMed
    Score: 0.005
  77. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford). 2023 03; 25(3):347-352.
    View in: PubMed
    Score: 0.005
  78. Technique for Robotic Pancreaticojejunostomy. J Am Coll Surg. 2023 05 01; 236(5):e12-e14.
    View in: PubMed
    Score: 0.005
  79. Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022. World J Surg. 2023 01; 47(1):11-34.
    View in: PubMed
    Score: 0.005
  80. Individual components of post-hepatectomy care pathways have differential impacts on length of stay. Am J Surg. 2023 01; 225(1):53-57.
    View in: PubMed
    Score: 0.005
  81. High-Contrast Detection of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery. Mol Pharm. 2022 11 07; 19(11):4241-4253.
    View in: PubMed
    Score: 0.005
  82. Bintrafusp alfa, an anti-PD-L1:TGF-? trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. Cancer Res Commun. 2022 09; 2(9):979-986.
    View in: PubMed
    Score: 0.005
  83. Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2023 Jan; 30(1):e1-e2.
    View in: PubMed
    Score: 0.005
  84. Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. 2023 Apr; 30(4):523-531.
    View in: PubMed
    Score: 0.005
  85. Understanding the association between clinical staging accuracy, treatment response, and survival among gastric cancer patients through Bayesian analysis. J Surg Oncol. 2022 Nov; 126(6):986-994.
    View in: PubMed
    Score: 0.005
  86. Opioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay. J Surg Res. 2022 10; 278:111-118.
    View in: PubMed
    Score: 0.005
  87. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer. 2022 07 01; 128(13):2529-2539.
    View in: PubMed
    Score: 0.005
  88. Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. J Am Coll Surg. 2022 07 01; 235(1):41-48.
    View in: PubMed
    Score: 0.005
  89. Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma. Ann Surg. 2022 03 01; 275(3):415-421.
    View in: PubMed
    Score: 0.005
  90. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. J Gastrointest Surg. 2022 04; 26(4):791-801.
    View in: PubMed
    Score: 0.005
  91. Early Experience of a Robotic Foregut Surgery Program at a Cancer Center: Video of Shared Steps in Robotic Pancreatoduodenectomy and Gastrectomy. Ann Surg Oncol. 2022 Jan; 29(1):285.
    View in: PubMed
    Score: 0.005
  92. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg. 2021 08 19; 108(8):968-975.
    View in: PubMed
    Score: 0.005
  93. Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol. 2021 Dec; 39:101648.
    View in: PubMed
    Score: 0.005
  94. Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal?Cancer. J Am Coll Surg. 2021 08; 233(2):272-284.e13.
    View in: PubMed
    Score: 0.005
  95. Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer. J Surg Oncol. 2021 May; 123(8):1724-1735.
    View in: PubMed
    Score: 0.005
  96. Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2021 07; 233(1):82-89.e1.
    View in: PubMed
    Score: 0.005
  97. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021 Mar; 36:138-146.
    View in: PubMed
    Score: 0.005
  98. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2021 01; 25(1):186-194.
    View in: PubMed
    Score: 0.005
  99. Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis. Ann Surg Oncol. 2021 Jun; 28(6):3186-3195.
    View in: PubMed
    Score: 0.005
  100. Short- and Long-Term Outcomes of a Transdiaphragmatic Approach for Simultaneous Resection of Colorectal Liver and Lung Metastases. J Gastrointest Surg. 2021 03; 25(3):641-649.
    View in: PubMed
    Score: 0.005
  101. External Retraction Technique for Robotic Pancreatoduodenectomy. J Am Coll Surg. 2020 11; 231(5):e8-e10.
    View in: PubMed
    Score: 0.005
  102. Neoadjuvant Treatment for Patients With Localized Pancreatic Adenocarcinoma: Are We There Yet? JAMA Oncol. 2020 08 01; 6(8):1163-1164.
    View in: PubMed
    Score: 0.005
  103. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg. 2020 08; 272(2):e106-e111.
    View in: PubMed
    Score: 0.005
  104. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. 2020 Sep; 34:182-185.
    View in: PubMed
    Score: 0.004
  105. Long-Term Assessment of Pancreatic Function After Pancreatectomy for Cystic Neoplasms. J Surg Res. 2020 03; 247:547-555.
    View in: PubMed
    Score: 0.004
  106. Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery. Clin Cancer Res. 2019 07 15; 25(14):4332-4342.
    View in: PubMed
    Score: 0.004
  107. Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma. J Natl Compr Canc Netw. 2019 02; 17(2):161-168.
    View in: PubMed
    Score: 0.004
  108. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer. J Surg Res. 2019 05; 237:41-49.
    View in: PubMed
    Score: 0.004
  109. Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology. 2018 11; 68(5):1879-1889.
    View in: PubMed
    Score: 0.004
  110. Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery. 2019 02; 165(2):307-314.
    View in: PubMed
    Score: 0.004
  111. Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer. Ann Surg. 2018 08; 268(2):303-310.
    View in: PubMed
    Score: 0.004
  112. Limitations of the National Cancer Data Base to Evaluate Early-Stage Anal Cancer Treatment Outcomes-Reply. JAMA Surg. 2018 07 01; 153(7):691-692.
    View in: PubMed
    Score: 0.004
  113. Management of Stage I Squamous Cell Carcinoma of the Anal Canal. JAMA Surg. 2018 03 01; 153(3):209-215.
    View in: PubMed
    Score: 0.004
  114. Sequential drain amylase to guide drain removal following pancreatectomy. HPB (Oxford). 2018 06; 20(6):514-520.
    View in: PubMed
    Score: 0.004
  115. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. J Surg Res. 2018 06; 226:15-23.
    View in: PubMed
    Score: 0.004
  116. Association of the Addition of Oral Antibiotics to Mechanical Bowel Preparation for Left Colon and Rectal Cancer Resections With Reduction of Surgical Site Infections. JAMA Surg. 2018 Feb 01; 153(2):114-121.
    View in: PubMed
    Score: 0.004
  117. Evidence-Based Management of Drains Following Pancreatic Resection: A Systematic Review. Pancreas. 2018 01; 47(1):12-17.
    View in: PubMed
    Score: 0.004
  118. National Quality Forum Colon Cancer Quality Metric Performance: How Are Hospitals Measuring Up? Ann Surg. 2017 12; 266(6):1013-1020.
    View in: PubMed
    Score: 0.004
  119. A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage. Ann Surg. 2017 09; 266(3):421-431.
    View in: PubMed
    Score: 0.004
  120. Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients. 2017 Mar 07; 9(3).
    View in: PubMed
    Score: 0.004
  121. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol. 2017 Feb; 115(2):144-150.
    View in: PubMed
    Score: 0.003
  122. Endocrine incidentalomas. Curr Probl Surg. 2016 May; 53(5):219-46.
    View in: PubMed
    Score: 0.003
  123. Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis. J Gastrointest Surg. 2015 Jan; 19(1):180-8; discussio 188.
    View in: PubMed
    Score: 0.003
  124. Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg. 2014 Jan; 18(1):16-24; discussion 24-5.
    View in: PubMed
    Score: 0.003
  125. In vivo fluorescence imaging of gastrointestinal stromal tumors using fluorophore-conjugated anti-KIT antibody. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S693-700.
    View in: PubMed
    Score: 0.003
  126. Therapeutic advances in pancreatic cancer. Gastroenterology. 2013 Jun; 144(6):1316-26.
    View in: PubMed
    Score: 0.003
  127. The battle of the sexes: women win out in gastrointestinal surgery. J Surg Res. 2011 Sep; 170(1):e23-8.
    View in: PubMed
    Score: 0.002
  128. Knockdown of the ?(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis. Int J Cancer. 2011 Dec 15; 129(12):2905-15.
    View in: PubMed
    Score: 0.002
  129. Density of surgeons is significantly associated with reduced risk of deaths from motor vehicle crashes in US counties. J Am Coll Surg. 2011 May; 212(5):862-6.
    View in: PubMed
    Score: 0.002
  130. Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Mol Pharm. 2010 Jun 07; 7(3):914-20.
    View in: PubMed
    Score: 0.002
  131. Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]. Proc Natl Acad Sci U S A. 2010 Jun 15; 107(24):10920-5.
    View in: PubMed
    Score: 0.002
  132. Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. Mol Cancer Ther. 2009 Jul; 8(7):1779-86.
    View in: PubMed
    Score: 0.002
  133. Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer. BMC Cancer. 2009 Apr 08; 9:106.
    View in: PubMed
    Score: 0.002
  134. Lower body negative pressure treadmill exercise is more comfortable and produces similar physiological responses as weighted vest exercise. Int J Sports Med. 2007 Jun; 28(6):501-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.